Sanofi - Aventis Pakistan Limited informed Pakistan Stock Exchange about the recommendations made by the board of directors in the meeting held at Karachi on April 28, 2020.

The agenda of the meeting was discussion of profit and loss account for quarter ended March 31, 2020 which portrayed a loss of Rs. 84,413 with loss per share 8.75 basic and diluted respectively.

Further, nil payment of cash dividend, bonus shares and right shares was agreed.

The announcement is available at:

https://dps.psx.com.pk/download/document/146811.pdf

Sanofi - Aventis Pakistan Limited was incorporated in Pakistan in 1997as a Public Limited Corporation. The foundations of the company have been laid under the Companies Ordnance, 1984. The company is engaged in the manufacturing and sale of pharmaceutical and consumer products. The shares of the company are quoted on the Karachi, Lahore and Islamabad Stock Exchanges of Pakistan. The registered office of the company is located at Karachi.

The site of the company is organized in four specialized and autonomous business units which aid the company with the manufacturing process. The manufacturing products of the company range from oral solids and liquid dosage forms to highly technical and sophisticated sterile products.

The symbol "SAPL" is being used by the stock exchanges for the shares of Sanofi - Aventis Pakistan Limited.

© Pakistan Press International, source Asianet-Pakistan